Nystatin Dosing for Oral Thrush
For mild oral thrush, use nystatin suspension (100,000 U/mL) at 4-6 mL four times daily for adults and children, or 2 mL four times daily for infants, continued for 7-14 days, though clotrimazole troches or miconazole buccal tablets are preferred first-line options. 1, 2
Dosing by Age Group
Infants
- Standard dose: 2 mL (200,000 units) four times daily 2
- Administration technique: Use dropper to place half the dose in each side of mouth; avoid feeding for 5-10 minutes 2
- Premature/low birth weight infants: 1 mL four times daily is effective based on limited studies 2
Children and Adults
- Dose: 4-6 mL (400,000-600,000 units) four times daily 2
- Administration: Place half the dose in each side of mouth; retain in mouth as long as possible before swallowing 2
Treatment Duration
- Continue for at least 48 hours after symptoms resolve and cultures confirm eradication of Candida albicans 2
- Guidelines recommend 7-14 days total treatment duration 1
Clinical Context and Positioning
Nystatin as Second-Line Therapy
Nystatin is classified as an alternative agent for mild oral thrush, not first-line therapy. The 2016 IDSA guidelines give nystatin a strong recommendation but note it is less preferred than clotrimazole troches (10 mg 5 times daily) or miconazole buccal tablets (50 mg once daily) 1. This positioning reflects moderate-quality evidence supporting nystatin versus high-quality evidence for the preferred agents.
When to Use Nystatin
Consider nystatin when:
- Clotrimazole or miconazole are unavailable or contraindicated
- Cost is a primary concern
- Patient cannot tolerate troches or buccal tablets
- Treating infants (where suspension formulation is advantageous)
When NOT to Use Nystatin
Escalate to systemic therapy with oral fluconazole (100-200 mg daily for 7-14 days) for moderate-to-severe disease 1. Do not persist with nystatin if:
- Symptoms are moderate to severe at presentation
- No clinical improvement after 5-7 days of treatment
- Patient is immunocompromised (fluconazole superior in this population) 3
Important Clinical Caveats
Efficacy Concerns
Research demonstrates nystatin has significantly lower cure rates compared to alternatives:
- In immunocompetent infants: 32% cure rate with nystatin vs. 100% with fluconazole 4
- In immunocompromised children: 51% cure with nystatin vs. 91% with fluconazole 3
- Miconazole gel achieved 84.7% cure by day 5 vs. 21.2% with nystatin 5
These studies consistently show nystatin requires longer treatment duration and has higher failure rates, though it remains effective when used appropriately for mild disease.
Administration Pitfalls
- Swish-and-swallow technique is critical: Simply swallowing the suspension reduces contact time and efficacy
- Timing matters: Avoid eating or drinking for 5-10 minutes after administration to maintain mucosal contact 2
- Denture wearers: Must disinfect dentures concurrently with antifungal therapy 1
Special Populations
- HIV-infected patients: Antiretroviral therapy is essential to reduce recurrence; consider fluconazole over nystatin 1
- Pregnancy: Can be used (no evidence of fetal harm), but only if clearly needed 2
- Nursing mothers: Use with caution as excretion in breast milk is unknown 2
Formulation Details
Available as 100,000 units/mL suspension in cherry or bubblegum flavors 2. The heterogeneous distribution in the GI tract means dosing must be consistent and adequate 6.